• 2014
    • Case Report on Treatment of Nuclear Paralysis Patients using Autologus Adipose Tissue-derived Stem Cells
    • Autologus Adipose Stem Cell Medicine for Degenerative Arthritis – clinically approved by Korea Food and Drug (2b/3 phase) Administration
    • Paper published – Result of Clinical Research on Treatment of Degenerative Arthritis using JointStem – STEM CELLS
    • Presented the result of JointStem clinical trial at 2014 AAOS Annual Meeting
    • Autologous Stem Cell Medicine for Degenerative Arthritis – clinically approved by US FDA (2 phase)
    • Patent Registrations
      • Cellular Therapeutic Agent Comprising Multipotent Stem Cells Derived From Human Adipose Tissue and Hair Follicle Cells (South Korea)
      • Composition which Induces Adipose-derived Adult Stem Cell Migration (US, Japan, Russia)
      • METHOD FOR PRODUCING STEM CELLS WITH A SIZE SUITABLE FOR INTRAVASCULAR ADMINISTRATION (South Korea)
      • Culture media and methods for culturing mesenchymal stem cell (Europe, US, Australia)
      • Method for Isolating and Culturing Adult Stem Cells Derived from Human Amniotic Epithelium (Canada)
      • Method for isolation, expansion and differentiation of a hair follicle stem cell, and a composition for hair reproduction (Japan)
    • Patent Applications
      • MEDIUM COMPOSITION FOR MAKING STEM CELLS FRESH (Europe, US, Canada, Brazil, Australia, China, etc.)
      •  METHOD AND COMPOSITION FOR PREVENTING DISRUPTION AND AGGREGATION OF STEM CELLS (Europe, US, Japan, China, India, Australia, etc.)
      • METHOD FOR PRODUCING STEM CELLS WITH A SIZE SUITABLE FOR INTRAVASCULAR ADMINISTRATION (Europe, US, China, Japan, etc.)
      • METHOD FOR PREPARING HIGH CONCENTRATION STEM CELLS (Europe, US, Brazil, Mexico, China, India, Japan, etc.)
      • COMPOSITION CONTAINING MESENCHYMAL STEM CELL CULTURE AND BASE FOR ENHANCING STEM CELL STABILITY (South Korea)
      • MEDIUM COMPOSITION FOR CULTURING STELL CELLS (South Korea)
  • 2013
    • Developed a culturing technology for making stem cells fresh
    • Successfully developed a small autologous adipose stem cell maintenance and cultivation technology
    • Patent Registrations
      • COMPOSITION WHICH INDUCES ADIPOSE-DERIVED ADULT STEM CELL MIGRATION (South Korea)
      • Composition for Treating of Ischemic Limb Disease Comprising Stem Cells Derived from Adipose Tissue (Europe, Japan, China)
      • Celluar Therapeutic Agent for Incontinence of Urine Comprising Stem Cells Originated from Decidua (China, Japan)
      • METHOD FOR PROLIFERATING A LARGE AMOUNT OF HAIR FOLLICLE STEM CELLS (South Korea)
      • Method for Isolating and Culturing Adult Stem Cells Derived from Human Amniotic Epithelium (US, Japan)
      • Culture media and methods for culturing mesenchymal stem cell (South Africa)
    • Patent Applications
      • MEDIA COMPOSITION FOR IMPROVING RENEWAL ABILITY OF STEM CELLS AND METHOD FOR CULTURING STEM CELLS USING SAME (South Korea)
      • STEM CELL COMPOSITION FOR INTRAVENOUS ADMINISTRATION (South Korea)
      • Culture media and methods for culturing mesenchymal stem cell (Europe, US, Australia)
  • 2012
    • Began the clinical research on the treatment of spinal cord injury
    • Signed a placental stem cell joint research agreement with Jeil Hospital
    • Provided gratuitous stem cell storage services for children with cerebral palsy
    • Signed a joint research and clincal test agreement with Science Academy Hospital, Russia
    • Signed a stem cell research agreement with Boramae Hospital, Seoul
    • Participated in RIO+20 Corporate Sustainability Forum, UN Global Compact (UNGC)
      • Held a presentation on overcoming rare and incurable diseases through adult stem cells and medical support for children with cerebral palsy
    • Case report on the treatment of cerebral palsy patients using adipose tissue derived stem cells
    • Paper published: the Effect and Stability of Autologus Derived Stem Cell Injection for Severe Lower Limb Ischemia Patients
    • Paper published: Clinical Application of Adipose Tissue Derived Stem Cells to Romberg’s Disease
    • Patent Registrations
      • Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (Vietnam)
      • Composition for Treating of Ischemic Limb Disease Comprising Stem Cells Derived from Adipose Tissue (Singapore)
      • Culture media and methods for culturing mesenchymal stem cell (South Korea)
  • 2011
    • Paper published – Safety of Intravenous Injection of Stem Cells – Stem cell & Development
    • Paper published – Treatment for Autoimmune Patients using Stem Cells
    • Signed an MOU for construction of a stem cell regenerative medicine center in Osong Medical Complex (Chungcheongbukdo)
    • Patent Registrations
      • Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (31 countries in Europe, Singapore, UK, Australia, Russia, Japan)
      • Composition for Treating of Critical Limb Ischemia Disease Comprising Stem Cells Derived from Adipose Tissue (Mexico)
      • Celluar Therapeutic Agent for Incontinence of Urine Comprising Stem Cells Originated from Decidua (South Korea)
  • 2010
    • Developed the technology for proliferating placenta-derived amniotic epithelial stem cells
    • Patent Registrations
      • Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (US)
  • 2009
    • Spinal cord injury treatment using autologous adipose tissue derived stem cells passes commercial clinical test
    • Succeeded in treating a patient with malignant rheumatoid arthritis using autologous adipose tissue derived stem cells (1st time in the world)
    • Succeeded in treating a patient with auto immune disease using autologous adipose tissue derived stem cells (1st time in the world)
    • Succeeded in treating a patient with severe atopy using autologous adipose tissue derived stem cells (1st time in the world)
    • Case report on treatment of a chronic cerebral hemorrhage patient using autologous adipose tissue derived stem cells
    • Developed a technology for customized stem cell cosmetic products (1st time in the world)
    • Patent Registrations – Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (Germany) – Method for isolation, expansion and differentiation of a hair follicle stem cell, and a composition for hair reproduction (Germany)
  • 2008
    • JointStem (degenerative arthritis medicine) passes clinical test (Phase 1, 2)
    • Romberg’s disease treatment using adipose stem cells passes researcher clinical test
    • Acquired a South Korean patent for a cord blood-derived stem cell technology (technology transfer from Seoul National University)
    • Urinary incontinence treatment using stem cells passes animal clinical test
    • Development of spinal cord injury medicine selected as a government-funded project
    • Patent Registrations
      • Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (South Korea)
      • Method for Isolating and Culturing Adult Stem Cells Derived from Human Amniotic Epithelium (South Korea)
      • Hair Restoration and Composition for Hair Restoration using Autologous Follicular Cells (South Korea)
  • 2007
    • Berger’s disease treatment using autologous adipose tissue derived stem cells passes commercial clinical test (Phase 1, 2)
    • Completed the safety test for adipose stem cell (Clinical Medicine Institute, Seoul National University)
    • Signed an MOU for public development of stem cell medicine with Boramae Hospital
    • Patent Registrations
      • Multipotent Stem Cell Derived from Human Adipose Tissue and Cellular Therapeutic Agents Comprising the Same (South Korea)
      • Method for Culturing and Proliferating of Hematopoietic Cells Through Co-culture with Adult Stem Cells (South Korea)
      • Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adipocyte
  • 2006
    • Cosmetic or Plastic Composition Comprising Multipotent Stem Cells Derived from Human Adipose Tissue, Fibroblast and Adipose or Adipocyte
    • Began the pre-clinical trial for stem cell medicine for cranial deficiency – Seoul Asan Medical Center
    • Signed an MOU for collaboration for stem cell research – Johns Hopkins University, US
    • Separated placental stem cell for the first time in South Korea Cultivation successful
    • Successfully treated severe spinal cord injury using stem cells